Searchable abstracts of presentations at key conferences in endocrinology

ea0056gp19 | Adrenal Case reports | ECE2018

Nonclassical congenital adrenal hyperplasia in a young patient with Type 1a Glycogen storage disease: is there a novel link between glucose metabolism and adrenal steroidogenesis?

Kandaraki Eleni , Papalou Olga , Spyridon Dourakis , Konstantoulakis Pantelis , Diamanti-Kandarakis Evanthia

Introduction: Glycogen storage disease type Ia is a rare genetic disorder that develops due to deficient activity of the enzyme glucose 6-phosphatase and manifests clinically early in life with hypoglycemia and failure to thrive, as well as with organ dysfunction, due to excess glycogen accumulation, including hepatomegaly and kidney dysfunction. Endocrine manifestations are commonly encountered in these patients. However, due to their rarity, endocrine dysfunction has not bee...

ea0056p137 | Endocrine tumours and neoplasia | ECE2018

Unraveling the incidence and clinical patterns of neuroendocrine neoplasms in Greece, through the experience of multipotent, specialized clinical centers.

Papalou Olga , Kandaraki Eleni , Papadakis Georgios , Nikou Georgios , Diamanti-Kandarakis Evanthia

Introduction: Neuroendocrine neoplasms (NENs) are a heterogeneous group of tumors arising from neuroendocrine cells in the endocrine and central nervous system, the natural history of which remains inadequately understood. Large epidemiological studies are gradually emerging from different countries worldwide, which contribute to the establishment of a spherical view about these tumors. The purpose of this study is to evaluate the epidemiological, clinical and pathological cha...

ea0056ep145 | Reproductive Endocrinology | ECE2018

The combination of cardiovascular risk factors in PCOS and the risk for cardiovascular disease events

Papadakis Georgios , Kandaraki Eleni , Papalou Olga , Vryonidou Andromachi , Diamanti-Kandarakis Evanthia

Objectives: • PCOS is defined by the presence of hyperandrogenism (clinical and/or biochemical), ovarian dysfunction (oligo-anovulation and/or polycystic ovaries), and the exclusion of related disorders.• Women are exposed to increased risk for cardiovascular disease, hypertension, type 2 diabetes mellitus and other metabolic complications• Cardiovascular disease (CVD) is one of the most common cause of mortality wor...

ea0090p590 | Calcium and Bone | ECE2023

Post-thyroidectomy development of posterior reversible encephalopathy syndrome (PRES) due to over-replacement of hypocalcemia

Papalou Olga , Katechakis Nikolaos , Koukoula Chrysoula , Beka Aikaterini , Baikousi Dimitra , Gkoufa Kyriaki , Mandrapylia Angeliki , Stratigou Theodora , Vassiliadi Dimitra , Tsagarakis Stylianos

A 61-year-old woman was admitted to the Emergency Department with generalized seizures. She reported general malaise, anorexia, headache and multiple episodes of vomiting that started about 12 h before admission. She had a history of recent thyroidectomy, and she was on oral calcium carbonate (3 gr/day) and alpha calcidol (3 mg/day). Non-contrast head CT scan was negative for major findings. Laboratory work up revealed hypercalcemia (corrected calcium 14,4 mg/dl), renal impair...

ea0032p579 | Female reproduction | ECE2013

White blood cells levels and PCOS: direct and indirect relationship with insulin resistance, but not with hyperandogenemia

Papalou Olga , Livadas Sarantis , Karachalios Athanasios , Benetatos Nektarios , Boutzios George , Dracou Maria , Kokkoris Panayotis , Diamanti-Kandarakis Evanthia

Background: Polycystic ovary syndrome (PCOS) is a complex metabolic disorder and hyperandrogenism and insulin resistance constitute the key players of syndrome pathogenesis. Another emerging important factor of PCOS is low-grade chronic inflammation. The aim of the present study was to investigate white blood cells count (WBC) in PCOS and assess its role as a possible marker of low-grade inflammation.Methods: Anthropometrical, metabolic and hormonal data...

ea0090p759 | Thyroid | ECE2023

Redifferentiation with Vemurafenib of BRAF-mutated Radioiodine Refractory Differentiated Metastatic Thyroid Cancer in two patients

Koukoula Chrysoula , Papalou Olga , Diamantopoulos Aristidis , Beka Aikaterini , Baikousi Dimitra , Antonopoulou Vasiliki , Ntali Georgia , Stratigou Theodora , Rontogianni Phoebe , Datseris Ioannis , Vassiliadi Dimitra , Tsagarakis Stylianos

Radioiodine treatment is the cornerstone of differentiated thyroid cancer (DTC) management. A number of thyroid cancers, however, become radioiodine-refractory (RAIR) and these represent about 60% of advanced DTCs and are responsible for the vast majority of DTC mortality. RAIR DTC has limited therapeutic options, mainly tyrosine kinase inhibitors that are associated with moderate efficacy and considerable toxicity. Reinducing NIS expression (redifferentiation) with the aim of...